Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 3
2017 3
2018 2
2019 2
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Detection of colon cancer recurrences during follow-up care by general practitioners vs surgeons.
Vos JAM, Sert E, Busschers WB, Duineveld LAM, Wieldraaijer T, Wind J, Donkervoort SC, Govaert MJPM, Beverdam FH, Smits AB, Bemelman WA, Heuff G, van Weert HCPM, van Asselt KM; I CARE study Group. Vos JAM, et al. Among authors: duineveld lam. J Natl Cancer Inst. 2023 May 8;115(5):523-529. doi: 10.1093/jnci/djad019. J Natl Cancer Inst. 2023. PMID: 36715623 Free PMC article. Clinical Trial.
Cost-effectiveness of general practitioner- versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial.
Vos JAM, El Alili M, Duineveld LAM, Wieldraaijer T, Wind J, Sert E, Donkervoort SC, Govaert MJPM, van Geloven NAW, van de Ven AWH, Heuff G, van Weert HCPM, Bosmans JE, van Asselt KM; ICARE study group. Vos JAM, et al. Among authors: duineveld lam. J Cancer Surviv. 2023 Apr 25. doi: 10.1007/s11764-023-01383-4. Online ahead of print. J Cancer Surviv. 2023. PMID: 37097550
Effect of general practitioner-led versus surgeon-led colon cancer survivorship care, with or without eHealth support, on quality of life (I CARE): an interim analysis of 1-year results of a randomised, controlled trial.
Vos JAM, Duineveld LAM, Wieldraaijer T, Wind J, Busschers WB, Sert E, Tanis PJ, Verdonck-de Leeuw IM, van Weert HCPM, van Asselt KM; I CARE study group. Vos JAM, et al. Among authors: duineveld lam. Lancet Oncol. 2021 Aug;22(8):1175-1187. doi: 10.1016/S1470-2045(21)00273-4. Epub 2021 Jul 2. Lancet Oncol. 2021. PMID: 34224671 Clinical Trial.
17 results